Digitalization of clinical trials will soon become the norm for pharma industry. In the industry's ongoing quest to bring new life-saving treatments to the world, telemedicine offers the potential to be an effective and a sustainable technology platform for improving the efficiency and quality of clinical trials. Most of the pharmaceutical companies are jumping into the bandwagon slowly but surely. Sensors, wearables, remote monitoring systems and sophisticated analytics hold the promise of ushering in highly efficient and insightful clinical trials. The new paradigm of digital clinical trials is likely to reduce the cost of bringing a scientific breakthrough to market. This in turn, bodes well for cost burden associated with innovative pharmaceuticals. How the intersection between clinical trials and medical practice evolves, as facilitated by digital technologies, is a broader topic to be explored in the future.